Home > Insider Trading > Filing (0001628280-19-004558)

Filing Details

Accession Number:: 0001628280-19-004558
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-04-22 17:40:20
Reporting Period:: 2019-04-18

Accepted Time:: 2019-04-22 17:40:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1576280	Guardant Health Inc.	GH	Services-Medical Laboratories (8071)	454139254

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1753789	J Michael Wiley	505 Penobscot Drive Redwood City CA 94063	Chief Legal Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2019-03-12	3,000	$0.00	435,358	No	5	G	Direct
Common Stock	Disposition	2019-04-18	30,297	$68.93	405,061	No	4	S	Direct
Common Stock	Disposition	2019-04-18	35,300	$69.64	369,761	No	4	S	Direct
Common Stock	Disposition	2019-04-18	15,801	$70.76	353,960	No	4	S	Direct
Common Stock	Disposition	2019-04-18	6,702	$71.40	347,258	No	4	S	Direct
Common Stock	Disposition	2019-04-18	1,900	$72.43	345,358	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	5	G	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

These shares represent shares that the reporting person donated as a gift to a donor advised fund administered by the Deseret Trust Company.
These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.24 to $69.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.24 to $70.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.24 to $71.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.24 to $72.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.29 to $72.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.